CFL2 and gastric cancer: This result is supported by the findings in GC cell lines by Bian and colleagues [82], who verified that CFL2 knockdown inhibits proliferation and migration of MGC803 cells and that high CFL2 expression is associated with poor prognosis in patients with GC [82], demonstrating the oncogenic function of CFL2.